SPECIAL REPORT

Healthy Horizons
A brand new series of weekly segments which will explore the macro and micro issues facing the global economy.

LATEST FROM OUR BLOGS

» More

- Farrell: The Market is Still Seeking Reassurance

MORE HEADLINES

» Markets | Economy | Companies

- Retail Sales Show Gain, But Manufacturing Gauge Slips

PHARMA'S MARKET VIDEO

» More

Cholesterol Drug Battle 1 hr ago
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.

Novo Nordisk CEO on Diabetes Epidemic

13 Nov 2009

Diabetes is a global epidemic that presents an estimated $25 billion drug and device market and some predict that number could double over the next several years. Lars Sorensen, CEO of Novo Nordisk, the world's largest diabetes care company, talks to CNBC's Mike Huckman.

Pharma & Social Media 12 Nov 2009
The FDA is holding meetings into big pharma's possible use of social media to sell their products. CNBC's Mike Huckman has the details.

"Friending" Big Pharma

12 Nov 2009

Big pharma is embracing social media, but how much can or should a tightly regulated sector be able to say on Facebook or Twitter? CNBC's Mike Huckman takes a closer look.

SNY Out with H1N1 Test Results 11 Nov 2009
Sanofi Aventis confirms that kids 9 and under need not one but two H1N1 shots, with CNBC's Mike Huckman.
Making The Vaccine 06 Nov 2009
Inside the big push to get enough H1N1 vaccines, with CNBC's Mike Huckman.

RSS FEED

» Help

Subscribe to this RSS feed
Stay up to date with Pharma's Market.

CNBC ON DIGG

Pharma's Market

Text Size

Jul.16

12:31 PM ET

Wednesday, 16 Jul 2008

Lilly's Sex Survey: Will It Have Desired Effect On Cialis?

Posted By:Mike Huckman

Topics:Medicine | Pharmaceuticals

Sectors:Insurance | Health Care Equipment and Services | Health Care | Pharmaceuticals

Lilly
More than ten years after Pfizer [PFE Loading... () ] brought Viagra to market and brought erectile dysfunction out of the closet a new survey says a lot of men are still too embarrassed to talk about impotence with their doctor.

The study, paid for by Clialis-maker Eli Lilly [LLY Loading... () ], shows nearly 40 percent of men have never broached the subject with their physician, even though 82 percent of men know ED could be a symptom of serious health problems.

You can read all sorts of other fun factoid findings of the survey here. LLY claims it interviewed the 300 men who are at least 45 years old "to further understand men's current beliefs about ED and DE treatment options, as well as the perceptions men have about communicating with their healthcare professional about ED."

Yeah, uh-huh, sure.

I'm guessin' they knew I couldn't resist blogging about ED.

Genentech Regenerates Avastin

Lilly has turned Cialis--the pill that lasts in your system for a day-and-a-half--into a blockbuster. And it recently launched a one-a-day version of the drug. Pfizer sold nearly half-a-billion dollars worth of Viagra in the first quarter of this year. GlaxoSmithKline [GSK Loading... () ], Schering-Plough [SGP Loading... () ] and the German Bayer[BAY Loading... () ] share Levitra which is an also-ran, me-too ED drug. But I do know one new Levitra convert. A certain co-worker, who will remain unnamed, recently told me he spent more than 300 bucks to fill a Levitra prescription his neighbor wrote for him. Mr. Anonymous said he'd grown frustrated with his primary care physician who would only write him tiny, apparently insufficient, prescriptions for Viagra.

I also wonder what, if any, impact General Motors' [GM Loading... () ]decision to cut healthcare benefits for retirees could have on ED drug sales. Especially if other companies follow GM's lead.